Bicara Therapeutics Inc.
BCAX
24 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:47 PM | Claire MazumdarDirector, Chief Executive Officer | Sale | 36,766 | $19.17 | $704.7K | 339,392(D) | View → |
| Mar 9, 2026 | Mar 9 8:06 PM | Mazumdar Claire | Proposed Sale | 36,766 | $19.17 | $704.7K | — | View → |
| Mar 6, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 3,817 | $18.75 | $71.6K | 339,392(D) | View → |
| Mar 5, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 1,786 | $18.74 | $33.5K | 339,392(D) | View → |
| Mar 4, 2026 | Mar 7 12:27 AM | Claire MazumdarDirector, Chief Executive Officer | Sale | 2,631 | $18.73 | $49.3K | 339,392(D) | View → |
| Mar 6, 2026 | Mar 6 9:01 PM | Mazumdar Claire | Proposed Sale | 3,817 | $19.80 | $75.6K | — | View → |
| Mar 3, 2026 | Mar 6 12:10 AM | Ryan CohlheppDirector, President and COO | Sale | 17,392 | $18.16 | $315.9K | 205,141(D) | View → |
| Mar 4, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 2,963 | $18.25 | $54.1K | 145,355(D) | View → |
| Mar 3, 2026 | Mar 6 12:08 AM | Ivan HyepChief Financial Officer | Sale | 13,555 | $18.22 | $246.9K | 145,355(D) | View → |
| Mar 4, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 16,300 | $18.52 | $301.9K | 55,286(D) | View → |
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Sale | 200 | $18.45 | $3.7K | 55,286(D) | View → |
| Mar 5, 2026 | Mar 5 9:04 PM | Mazumdar Claire | Proposed Sale | 1,786 | $18.74 | $33.5K | — | View → |
| Mar 4, 2026 | Mar 4 9:32 PM | Hyep Ivan | Proposed Sale | 2,963 | $18.25 | $54.1K | — | View → |
| Mar 4, 2026 | Mar 4 9:31 PM | Mazumdar Claire | Proposed Sale | 2,631 | $18.73 | $49.3K | — | View → |
| Mar 4, 2026 | Mar 4 9:21 PM | Raben David | Proposed Sale | 16,300 | $18.52 | $301.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:48 PM | Hyep Ivan | Proposed Sale | 13,555 | $18.22 | $246.9K | — | View → |
| Mar 3, 2026 | Mar 3 9:11 PM | Raben David | Proposed Sale | 200 | $18.45 | $3.7K | — | View → |
| Mar 3, 2026 | Mar 3 9:09 PM | Cohlhepp Ryan | Proposed Sale | 17,392 | $18.16 | $315.9K | — | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 300,000 | $16.00 | $4.8M | 4,603,418(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Sale | 3,631 | $18.04 | $65.5K | 209,641(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 12:06 AM | David RabenChief Medical Officer | Option Exercise | 200 | $3.79 | 69,213(D) | View → |
| Feb 26, 2026 | Mar 2 9:22 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,200,000 | $0.0001 | 2,200,000(I) | View → |
| Feb 25, 2026 | Feb 27 9:13 PM | Ryan CohlheppDirector, President and COO | Option Exercise | 3,108 | $3.79 | 138,226(D) | View → |
| Feb 2, 2026 | Feb 4 9:38 PM | Ryan CohlheppDirector, President and COO | Grant/Award | 300,000 | $16.76 | 300,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:37 PM | Claire MazumdarDirector, Chief Executive Officer | Grant/Award | 450,000 | $16.76 | 450,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:36 PM | David RabenChief Medical Officer | Grant/Award | 100,000 | $16.76 | 100,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:35 PM | Ivan HyepChief Financial Officer | Grant/Award | 125,000 | $16.76 | 125,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:34 PM | Lara MeisnerChief Legal Officer | Grant/Award | 90,000 | $16.76 | 90,000(D) | View → |
| Jan 22, 2026 | Jan 26 9:33 PM | Ivan HyepChief Financial Officer | Option Exercise | 1,882 | $3.79 | 65,462(D) | View → |
← Previous
Page 2 of 2